4//SEC Filing
Pursglove Geordan Garrett 4
Accession 0001641172-25-018489
CIK 0001335105other
Filed
Jul 8, 8:00 PM ET
Accepted
Jul 9, 6:37 PM ET
Size
5.7 KB
Accession
0001641172-25-018489
Insider Transaction Report
Form 4
Pursglove Geordan Garrett
DirectorCEO and Chairman of the Board
Transactions
- Award
Options to Purchase Common Stock
2025-07-03+350,000→ 350,000 totalExercise: $2.83From: 2025-07-03Exp: 2030-07-03→ Common (350,000 underlying)
Footnotes (1)
- [F1]Effective July 3, 2025, the reporting person was granted stock options to purchase an aggregate of 350,000 shares vesting 50% on the effective date, 25% on September 30,2025 and 25% on December 31,2025. The grant was a signing bonus for the reporting person entering into an employment agreement with the issuer. The exercise price is $2.83 per share.
Documents
Issuer
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
CIK 0001335105
Entity typeother
Related Parties
1- filerCIK 0002073519
Filing Metadata
- Form type
- 4
- Filed
- Jul 8, 8:00 PM ET
- Accepted
- Jul 9, 6:37 PM ET
- Size
- 5.7 KB